Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses
David C. Henderson, Brenda Vincenzi, Norte García Andrea, et al.
The Lancet Psychiatry (2015) Vol. 2, Iss. 5, pp. 452-464
Closed Access | Times Cited: 251

Showing 1-25 of 251 citing articles:

Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Brenda W.J.H. Penninx, Sjors M. M. Lange
Dialogues in Clinical Neuroscience (2018) Vol. 20, Iss. 1, pp. 63-73
Open Access | Times Cited: 429
20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
Heidi Taipale, Antti Tanskanen, Juha Mehtälä, et al.
World Psychiatry (2020) Vol. 19, Iss. 1, pp. 61-68
Open Access | Times Cited: 306
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Madhubhashinee Dayabandara, Raveen Hanwella, S. S. Ratnatunga, et al.
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 2231-2241
Open Access | Times Cited: 253
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Robin M. Murray, Diego Quattrone, Sridhar Natesan, et al.
The British Journal of Psychiatry (2016) Vol. 209, Iss. 5, pp. 361-365
Open Access | Times Cited: 213
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder
Julie Rask Larsen, Louise Vedtofte, Mathilde S. L. Jakobsen, et al.
JAMA Psychiatry (2017) Vol. 74, Iss. 7, pp. 719-719
Open Access | Times Cited: 177
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
Jari Tiihonen, Antti Tanskanen, Heidi Taipale
American Journal of Psychiatry (2018) Vol. 175, Iss. 8, pp. 765-773
Open Access | Times Cited: 162
Severe mental illness: cardiovascular risk assessment and management
Christoffer Polcwiartek, Kevin O’Gallagher, Daniel J. Friedman, et al.
European Heart Journal (2024) Vol. 45, Iss. 12, pp. 987-997
Open Access | Times Cited: 20
Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry
Hon‐Cheong So, Carlos Kwan‐Long Chau, Wan-To Chiu, et al.
Nature Neuroscience (2017) Vol. 20, Iss. 10, pp. 1342-1349
Closed Access | Times Cited: 153
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
Nina Dedic, Heather Dworak, Courtney Zeni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13185-13185
Open Access | Times Cited: 77
In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis
Blanca Fernández-Abascal, Paula Suárez‐Pinilla, Carlos Cobo-Corrales, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 535-568
Open Access | Times Cited: 61
Associations between depressive, anxiety, stress symptoms and elevated blood pressure: Findings from the CHCN-BTH cohort study and a two-sample Mendelian randomization analysis
Han Qi, Fuyuan Wen, Yunyi Xie, et al.
Journal of Affective Disorders (2023) Vol. 341, pp. 176-184
Closed Access | Times Cited: 23
Relationship between severe mental illness and physical multimorbidity: a meta-analysis and call for action
Damiano Pizzol, Mike Trott, Laurie T. Butler, et al.
BMJ Mental Health (2023) Vol. 26, Iss. 1, pp. e300870-e300870
Open Access | Times Cited: 22
The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol
Calogero Longhitano, Sabine Finlay, Isabella Peachey, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 10
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder
Susan L. McElroy, Anna I. Guerdjikova, Thomas J. Blom, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 8
Access to primary and specialized somatic health care for persons with severe mental illness: a qualitative study of perceived barriers and facilitators in Swedish health care
Elisabeth Björk Brämberg, Jarl Torgerson, Anna Kjellström, et al.
BMC Family Practice (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 73
Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up
Kayoko Isomura, Gustaf Brander, Zheng Chang, et al.
Biological Psychiatry (2017) Vol. 84, Iss. 5, pp. 324-331
Open Access | Times Cited: 72
Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits
Hon‐Cheong So, K. L. Chau, Fu‐Kiu Ao, et al.
Psychological Medicine (2018) Vol. 49, Iss. 8, pp. 1286-1298
Open Access | Times Cited: 68
Cardiovascular disease in patients with schizophrenia
Leonard Kritharides, Vincent Chow, Tim Lambert
The Medical Journal of Australia (2017) Vol. 206, Iss. 2, pp. 91-95
Closed Access | Times Cited: 66
Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits
D. C. Chen, Xin Du, Guo-He Yin, et al.
Psychological Medicine (2016) Vol. 46, Iss. 15, pp. 3219-3230
Closed Access | Times Cited: 65
Dysregulated Lipid Metabolism Precedes Onset of Psychosis
Alex M. Dickens, Partho Sen, Matthew J. Kempton, et al.
Biological Psychiatry (2020) Vol. 89, Iss. 3, pp. 288-297
Open Access | Times Cited: 62
Hypothalamic dopamine signalling regulates brown fat thermogenesis
Cintia Folgueira, Daniel Beiroa, Begoña Porteiro, et al.
Nature Metabolism (2019) Vol. 1, Iss. 8, pp. 811-829
Open Access | Times Cited: 60
Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders
Gustaf Brander, Kayoko Isomura, Zheng Chang, et al.
JAMA Neurology (2019) Vol. 76, Iss. 4, pp. 454-454
Open Access | Times Cited: 54
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 53
Body roundness index is a superior indicator to associate with the cardio‐metabolic risk: evidence from a cross‐sectional study with 17,000 Eastern-China adults
Jinjian Xu, Liqun Zhang, Qiong Wu, et al.
BMC Cardiovascular Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 52
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight
Simone Theilade, Mikkel Christensen, Tina Vilsbøll, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. S1, pp. 17-35
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top